Coronary angioscopic evaluation for serial changes of luminal appearance after pharmacological and catheter interventions

Circulation Journal

Volumn 74, Issue 2, 2010, Pages 240-245

  Takano, Masamichi ^a   Mizuno, Kyoichi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Angioscopy; Drugs; Plaque; Stents; Thrombus

Indexed keywords

ATORVASTATIN; BEZAFIBRATE; STATIN;

ACUTE CORONARY SYNDROME; ANGIOSCOPY; ATHEROSCLEROTIC PLAQUE; BARE METAL STENT; CORONARY ARTERY; DRUG ELUTING STENT; HEART CATHETER; HUMAN; INTIMA; NONHUMAN; REVIEW; STENT THROMBOSIS;

ACUTE CORONARY SYNDROME; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANGIOSCOPY; ANIMALS; CARDIOVASCULAR AGENTS; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; HUMANS; METALS; PREDICTIVE VALUE OF TESTS; PROSTHESIS DESIGN; RISK ASSESSMENT; STENTS; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 75749103372     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-0769     Document Type: Review

References (72)

1. Takano M, Mizuno K. Angioscopic findings after drug-eluting stent implantation. Hertz 2007; 32: 281-286.
2. Sakai S, Mizuno K, Yokoyama S, Tanabe J, Shinada T, Seimiya K, et al. Morphologic changes in infarct-related plaque after coronary stent placement: A serial angioscopy study. J Am Coll Cardiol 2003; 42: 1558-1565.
3. MacNeill BD, Lowe HC, Takano M, Fuster V, Jang IK. Intravascular modalities for detection of vulnerable plaque: Current status. Arterioscler Thromb Vasc Biol 2003; 23: 1333-1342.
4. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995; 92: 657-671.
5. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, et al. From vulnerable plaque to vulnerable patient: A call for new definitions and risk assessment strategies: Part I. Circulation 2003; 108: 1664-1672.
6. Honda Y, Fitzgerald PJ. Frontiers in intravascular imaging technologies. Circulation 2008; 117: 2024-2037.
7. Waxman S, Ishibashi F, Muller JE. Detection and treatment of vulnerable plaques and vulnerable patients: Novel approaches to prevention of coronary events. Circulation 2006; 114: 2390-2411.
8. Takano M, Mizuno K, Yokoyama S, Seimiya K, Ishibashi F, Okamatsu K, et al. Changes in coronary plaque color and morphology by lipid-lowering therapy with atorvastatin: Serial evaluation by coronary angioscopy. J Am Coll Cardiol 2003; 42: 680-686.
9. Takano M, Ohba T, Inami S, Seimiya K, Sakai S, Mizuno K. Angioscopic differences in neointimal coverage and in persistence of thrombus between sirolimus-eluting stents and bare metal stents after a 6-month implantation. Eur Heart J 2006; 27: 2189-2195.
10. Kawano T, Honye J, Takayama T, Yokoyama S, Chiku M, Ando H, et al. Compositional analysis of angioscopic yellow plaques with intravascular ultrasound radiofrequency data. Int J Cardiol 2008; 125: 74-78.
11. Takano M, Jang IK, Inami S, Yamamoto M, Murakami D, Okamatsu K, et al. In-vivo comparison of optical coherence tomography and angioscopy for the evaluation of coronary plaque characteristics. Am J Cardiol 2008; 101: 471-476.
12. Yamamoto M, Takano M, Okamatsu K, Murakami D, Inami S, Xie Y, et al. Relationship between thin cap fibroatheroma identified by virtual histology and angioscopic yellow plaque in quantitative analysis with colorimetry. Circ J 2009; 73: 497-502.
13. Ueda Y, Ohtani T, Shimizu M, Hirayama A, Kodama K. Assessment of plaque vulnerability by angioscopic classification of plaque color. Am Heart J 2004; 148: 333-335.
14. Ishibashi F, Mizuno K, Kawamura A, Singh PP, Nesto RW, Waxman S. High yellow color intensity by angioscopy with quantitative colorimetry to identify high-risk features in culprit lesions of patients with acute coronary syndromes. Am J Cardiol 2007; 100: 1207-1211.
15. Inami S, Ishibashi F, Waxman S, Okamatsu K, Seimiya K, Takano M, et al. Multiple yellow plaques assessed by angioscopy with quantitative colorimetry in patients with myocardial infarction. Circ J 2008; 72: 399-403.
16. Okada K, Ueda Y, Oyabu J, Ogasawara N, Hirayama A, Kodama K. Plaque color analysis by the conventional yellow-color grading system and quantitative measurement using LCH color space. J Interv Cardiol 2007; 20: 324-334.
17. Kawasaki M, Takatsu S, Noda T, Sano K, Ito Y, Hayakawa K, et al. In vivo quantitative tissue characterization of human coronary arterial plaques by use of integrated backscatter intravascular ultrasound and comparison with angioscopic findings. Circulation 2002; 105: 2487-2492.
18. Kubo T, Imanishi T, Takarada S, Kuroi A, Ueno S, Yamano T, et al. Implication of plaque color classification for assessing plaque vulnerability: A coronary angioscopy and optical coherence tomography investigation. JACC Cardiovasc Interv 2008; 1: 74-80.
19. Ishibashi F, Yokoyama S, Miyahara K, Dabreo A, Weiss ER, Iafrati M, et al. Quantitative colorimetry of atherosclerotic plaque using the L*a*b* color space during angioscopy for the detection of lipid cores underneath thin fibrous cap. Int J Cardiovasc Imaging 2007; 6: 679-691.
20. Takano M, Mizuno K, Okamatsu K, Yokoyama S, Ohba T, Sakai S. Mechanical and structural characteristics of vulnerable plaques: Analysis by coronary angioscopy and intravascular ultrasound. J Am Coll Cardiol 2001; 38: 99-104.
21. Okamatsu K, Takano M, Sakai S, Ishibashi F, Uemura R, Takano T, et al. Elevated troponin T levels and lesion characteristics in non-ST elevation acute coronary syndromes. Circulation 2004; 109: 465-470.
22. Mizuno K, Miyamoto A, Satomura K, Kurita A, Arai T, Sakurada M, et al. Angioscopic morphology in patients with acute coronary disorders. Lancet 1991; 337: 809-812.
23. Mizuno K, Satomura K, Miyamoto A, Arakawa K, Shibuya T, Arai T, et al. Angioscopic evaluation of coronary-artery thrombi in acute coronary syndromes. N Engl J Med 1992; 326: 287-291.
24. Uchida Y, Nakamura F, Tomaru T, Morita T, Oshima T, Sasaki T, et al. Prediction of acute coronary syndromes by percutaneous coronary angioscopy in patients with stable angina. Am Heart J 1995; 130: 195-203.
25. Ohtani T, Ueda Y, Mizote I, Oyabu J, Okada K, Hirayama A, et al. Number of yellow plaques detected in a coronary artery is associated with future risk of acute coronary syndrome: Detection of vulnerable patients by angioscopy. J Am Coll Cardiol 2006; 47: 2194-2200.
26. McFadden E, Stabile E, Regar E, Cheneau E, Ong ATL, Kinnaird T, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004; 364: 1519-1521.
27. Alfonso F. The "vulnerable" stent: Why so dreadful? J Am Coll Cardiol 2008; 51: 2403-2406.
28. Waxman R. Late stent thrombosis-the "vulnerable" stent. Catheter Cardiovasc Interv 2007; 70: 54-56.
29. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, et al. Pathology of drug-eluting stents in humans: Delayed healing and late thrombotic risk. J Am Coll Cardiol 2006; 48: 193-202.
30. Fin AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, et al. Pathological correlates of late drug-eluting stent thrombosis: Strut coverage as a marker of endothelialization. Circulation 2007; 115: 2435-2441.
31. Cook S, Wenaweser P, Togni M, Billinger M, Morger C, Seiler C, et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation 2007; 115: 2426-2434.
32. Ueda Y, Nanto S, Komamura K, Kodama K. Neointimal coverage of stents in human coronary arteries observed by angioscopy. J Am Coll Cardiol 1994; 23: 341-346.
33. Kotani J, Awata M, Nanto S, Uematsu M, Oshima F, Minamiguchi H, et al. Incomplete neointimal coverage of sirolimus-eluting stents: Angioscopic findings. J Am Coll Cardiol 2006; 47: 2108-2111.
34. Oyabu J, Ueda Y, Ogasawara N, Okada K, Hirayama A, Kodama K. Angioscopic evaluation of neointima coverage: Sirolimus drug-eluting stent versus bare metal stent. Am Heart J 2006; 152: 1168-1174.
35. Xie Y, Takano M, Murakami D, Yamamoto M, Okamatsu K, Inami S, et al. Comparison of neointimal coverage by optical coherence tomography of a sirolimus-eluting stent versus a bare metal stent three months after implantation. Am J Cardiol 2008; 102: 27-31.
36. Takano M, Inami S, Jang IK, Yamamoto M, Murakami D, Seimiya K, et al. Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation. Am J Cardiol 2007; 99: 1033-1038.
37. Takano M, Yamamoto M, Inami S, Murakami D, Seimiya K, Ohba T, et al. Long-term follow-up evaluation after sirolimus-eluting stent implantation by optical coherence tomography: Do uncovered struts persist? J Am Coll Cardiol 2008; 51: 968-969.
38. Murakami D, Takano M, Yamamoto M, Inami S, Ohba T, Seino Y, et al. Advanced neointimal growth is not associated with a low risk of in-stent thrombus: Optical coherence tomographic findings after first-generation drug-eluting stents implantation. Circ J 2009; 73: 1627-1634.
39. Takano M, Yamamoto M, Murakami D, Inami S, Okamatsu K, Seimiya K, et al. Lack of association large angiographic late loss and low risk of in-stent thrombus: Angioscopic comparison between paclitaxel- and sirolimus-eluting stent. Circ Cardiovasc Intervent 2008; 1: 20-27.
40. Takano M, Mizuno K. Late coronary thrombosis in a sirolimus-eluting stent due to the lack of neointimal coverage. Eur Heart J 2006; 27: 1133.
41. Osawa H, Uchida Y, Fujimori Y, Hirose J, Noike H, Tokuhiro K, et al. Angioscopic evaluation of stabilizing effects of an antilipidemic agent, bezafibrate, on coronary artery plaques in patients with coronary artery disease: A multicenter prospective study. Jpn Heart J 2002; 43: 319-331.
42. Takano M, Inami S, Ishibashi F, Okamatsu K, Seimiya K, Ohba T, et al. Angioscopic follow-up study of non-culprit ruptured plaques. J Am Coll Cardiol 2005; 45: 652-658.
43. Hirayama A, Saito S, Ueda Y, Takayama T, Honye J, Komatsu S, et al. Qualitative and quantitative changes in coronary plaque associated with atorvastatin therapy. Circ J 2009; 73: 718-725.
44. Asakura M, Ueda Y, Yamaguchi O, Adachi T, Hirayama A, Hori M, et al. Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction: An angioscopic study. J Am Coll Cardiol 2001; 37: 1284-1288.
45. Takarada S, Imanishi T, Kubo T, Tanimoto T, Kitabata H, Nakamura N, et al. Effect of statin therapy on coronary fibrous-cap thickness in patients with acute coronary syndrome: Assessment by optical coherence tomography study. Atherosclerosis 2009; 202: 491-497.
46. Nissen SE, Tuzcu ME, Libby P, Thompson PD, Ghali M, Garza D, et al. CAMELOT Investigators. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: The CAMELOT study: A randomized control trial. JAMA 2004; 292: 2217-2225.
47. Nissen SE, Nicholls SJ, Wolski K, Nesto R, Kupfer S, Perez A, et al; PERISCOPE Investigators. Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: The PERISCOPE randomized controlled trial. JAMA 2008; 299: 1561-1573.
48. Asakura M, Ueda Y, Nanto S, Hirayama A, Adachi T, Kitakaze M, et al. Remodeling of in-stent neointima, which become thinner and transparent over 3 years: Serial angiographic and angioscopic follow-up. Circulation 1998; 97: 2003-2006.
49. Ichikawa M, Mishima M. Neointimal regression-induced incomplete coverage of a bare-metal stent in the left main trunk: Serial angiographic and angioscopic evidence obtained by 5-year follow-up. Catheter Cardiovasc Interv 2009; 73: 787-790.
50. Yokoyama S, Takano M, Yamamoto M, Inami S, Sakai S, Okamatsu K, et al. Extended follow-up by serial angioscopic observation for bare-metal stents in native coronary arteries: From healing response to atherosclerotic transformation of neointima. Circ Cardiovasc Intervent 2009; 2: 205-212.
51. Takano M, Yamamoto M, Mizuno K. Two cases of coronary stent thrombosis very late after bare-metal stenting. JACC Cardiovasc Interv 2009; 2: 1286-1287.
52. Awata M, Kotani J, Uematsu M, Morozumi T, Ohnishi T, Iida O, et al. Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation: Comparison with bare-metal stents. Circulation 2007; 116: 910-916.
53. Isner JM, Kearney M, Bortman S, Passeri J. Apoptosis in human atherosclerosis and restenosis. Circulation 1995; 91: 2703-2711.
54. Inoue K, Abe K, Shirai S, Nishiyama K, Yamada T, Sakai K, et al. Pathological analyses of long-term intracoronary Palmatz-Schatz stenting: Is it efficacy permanent? Cardiovasc Pathol 2004; 13: 109-115.
55. Takano M, Yamamoto M, Inami S, Murakami D, Ohba T, Seino Y, et al. Appearance of lipid-laden intima and neovascularization after implantation of bare-metal stents: Extended late phase observation by intracoronary optical coherence tomography. J Am Coll Cardiol 2009 (in press).
56. Farb A, Burke AP, Kolodgie FD, Virmani R. Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 2003; 108: 1701-1706.
57. Daeman J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large two-institutional cohort study. Lancet 2007; 369: 678.
58. Awata M, Nanto S, Uematsu M, Morozumi T, Watanebe T, Onishi T, et al. Heterogeneous arterial healing in patients following paclitaxel-eluting stent implantation: Comparison with sirolimus eluting stents. JACC Cardiovasc Interv 2009; 2: 453-458.
59. Yamamoto M, Okamatsu K, Inami S, Takano M, Yokoyama S, Ohba T, et al. Relationship between neointimal coverage of sirolimus-eluting stents and lesion characteristics: A study with serial coronary angioscopy. Am Heart J 2009; 158: 99-104.
60. Takano M, Murakami D, Mizuno K. Overlapping hybrid stenting with a sirolimus-eluting stent and a bare metal stent. Int J Cardiol 2007; 118: e8-e10.
61. Ichikawa M, Yutani C, Hayashi T, Nakata T, Iwata A, Lim YJ, et al. Angioscopic findings of delayed healing at sites of sirolimus-eluting stent overlap after 21-month implantation. Int J Cardiol 2008; 129: e10-e11.
62. Takano M, Jang IK, Mizuno K. Neointimal proliferation around malapposed struts of a sirolimus-eluting stent: Optical coherence tomography findings. Eur Heart J 2006; 27: 1763.
63. Higo T, Ueda Y, Oyabu J, Okada K, Nishio M, Hirata A, et al. Atherosclerotic and thrombogenic neointima formed over sirolimus drug-eluting stent: An angioscopic study. JACC Cardiovasc Imaging 2009; 2: 616-624.
64. Murakami D, Takano M, Yamamoto M, Inami S, Ohba T, Seino Y, et al. Novel neointimal formation over sirolimus-eluting stents identified by coronary angioscopy and optical coherence tomography. J Cardiol 2009; 53: 311-313.
65. Kawakami H, Matsuoka H, Oshima A, Kono T, Shigemi S. A case of a newly developed yellow intima at stent placed site 1 year after sirolimus-eluting stent placement: Angioscopic findings. J Cardiol 2009; 54: 153-157.
66. Takano M, Yamamoto M, Xie Y, Murakami D, Inami S, Okamatsu K, et al. Serial long-term evaluation of neointimal stent coverage and thrombus after sirolimus-eluting stent implantation by use of coronary angioscopy. Heart 2007; 93: 1353-1356.
67. Awata M, Nanto S, Uematsu M, Morozumi T, Watanebe T, Onishi T, et al. Angioscopic comparison of neointimal coverage between zotarolimus- and sirolimus-eluting stents. J Am Coll Cardiol 2008; 52: 789-790.
68. Kim JS, Jang IK, Kim JS, Kim TH, Takano M, Kume T, et al. Optical coherence tomography evaluation of zotarolimus-eluting stents at 9 month follow-up: Comparison with sirolimus-eluting stents. Heart 2009; 95: 1907-1912.
69. Finn AV, Kolodgie FD, Harnek J, Guerrero LJ, Acampado E, Tefera K, et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation 2005; 112: 270-278.
70. Nanto S, Uematsu M, Ohara T, Morozumi T, Kotani J, Nishio M, et al. Disappearance of intima over the stent and ulcer formation after intracoronary radiation for in-stent restenosis: Angioscopic findings in human coronary arteries. Circ J 2003; 67: 366-368.
71. Okada M, Tamai H, Kyo E, Kosuga K, Hata T, Nakamura T, et al. Serial angioscopic findings after successful intracoronary brachytherapy for in-stent restenosis. Am J Cardiol 2006; 97: 21-25.
72. Takano M, Yamamoto M, Inami S, Xie Y, Murakami D, Okamatsu K, et al. Delayed endothelialization after polytetrafluoroethylene-covered stent implantation for coronary aneurysm. Circ J 2009; 73: 190-193.